DELFI Diagnostics
Biotechnology ResearchMaryland, United States51-200 Employees
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Insights
Key Personnel Expansion DELFI Diagnostics recently appointed Robert Guigley as Chief Commercial Officer and Thomas Russo as Chief Financial Officer. This indicates a focus on strengthening the executive team to drive sales and business growth.
Strategic Partnerships Through partnerships with companies like Incendia Therapeutics, DELFI Diagnostics is exploring advanced treatment monitoring tests in clinical trials, presenting an opportunity to leverage these collaborations to expand its market reach and generate sales leads.
Equity Investment With an equity investment from Merck Global Health Innovation Fund, DELFI Diagnostics has received financial support to further develop its innovative cancer detection technologies. This financial backing can provide stability and resources for increased sales initiatives.
Product Integration The integration of DELFI Diagnostics' FirstLook Lung test into primary care settings at OSF locations signifies a potential opportunity to showcase the product's effectiveness and drive sales through successful implementation and expansion within healthcare facilities.
Cutting-Edge Technology Utilizing artificial intelligence and whole genome sequencing, DELFI Diagnostics offers advanced solutions for cancer detection. Highlighting the technology-driven nature of the company can appeal to tech-savvy healthcare providers and institutions, presenting a sales advantage in a competitive market.
Similar companies to DELFI Diagnostics
Genomic Health
501
$100M$1BInvitae
1K$100M$1BGRAIL
1.4K$100M$1BNatera
3.8K$100M$1BGuardant Health
2.9K$100M$1BMyriad Genetics
2.6K$100M$1BExact Sciences
5.7K$1BFoundation Medicine
1.9K$100M$1BIllumina
9.1K$1B10x Genomics
2.2K$100M$1B
DELFI Diagnostics Tech Stack
DELFI Diagnostics uses 8 technology products and services including Kubernetes, Jamf, Atlassian Jira, and more. Explore DELFI Diagnostics's tech stack below.
- KubernetesContainerization
- JamfEnterprise Mobility Management
- Atlassian JiraIssue Trackers
- scikit-learnMachine Learning
- LinuxProgramming Languages
- BambooHRRecruitment Marketing
- Google Tag ManagerTag Management
- TailwindVisual And User Generated Content Marketing
Media & News
DELFI Diagnostics's Email Address Formats
DELFI Diagnostics uses at least 1 format(s):
| DELFI Diagnostics Email Formats | Percentage |
| Last@delfidiagnostics.com | 69% |
| First.Last@delfidiagnostics.com | 30% |
| First.L@delfidiagnostics.com | 1% |
Frequently Asked Questions
Where is DELFI Diagnostics's headquarters located?
DELFI Diagnostics's main headquarters is located at 2809 Boston St Suite 503 Baltimore, Maryland 21224 US. The company has employees across 5 continents, including North AmericaAfricaSouth America. What is DELFI Diagnostics's official website and social media links?
DELFI Diagnostics's official website is delfidiagnostics.com and has social profiles on LinkedIn.How much revenue does DELFI Diagnostics generate?
As of November 2024, DELFI Diagnostics's annual revenue reached $15M. What is DELFI Diagnostics's SIC code NAICS code?
DELFI Diagnostics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does DELFI Diagnostics have currently?
As of November 2024, DELFI Diagnostics has approximately 198 employees across 5 continents, including North AmericaAfricaSouth America. Key team members include Chief Commercial Officer: R. G.Chief Financial Officer: T. R.Chief Scientific Officer: N. D.. Explore DELFI Diagnostics's employee directory with LeadIQ.What industry does DELFI Diagnostics belong to?
DELFI Diagnostics operates in the Biotechnology Research industry. What technology does DELFI Diagnostics use?
DELFI Diagnostics's tech stack includes KubernetesJamfAtlassian Jirascikit-learnLinuxBambooHRGoogle Tag ManagerTailwind. What is DELFI Diagnostics's email format?
DELFI Diagnostics's email format typically follows the pattern of . Find more DELFI Diagnostics email formats with LeadIQ. How much funding has DELFI Diagnostics raised to date?
As of November 2024, DELFI Diagnostics has raised $225M in funding. The last funding round occurred on Jul 18, 2022 for $225M.When was DELFI Diagnostics founded?
DELFI Diagnostics was founded in 2019.
Company Overview
- Headquarters
- 2809 Boston St Suite 503 Baltimore, Maryland 21224 US
- Website
- delfidiagnostics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2019
- Employees
- 51-200
Funding & Financials
- $225M
DELFI Diagnostics has raised a total of $225M of funding over 3 rounds. Their latest funding round was raised on Jul 18, 2022 in the amount of $225M.
- $10M$50M
DELFI Diagnostics's revenue is in the range of $10M$50M
Funding & Financials
- $225M
DELFI Diagnostics has raised a total of $225M of funding over 3 rounds. Their latest funding round was raised on Jul 18, 2022 in the amount of $225M.
- $10M$50M
DELFI Diagnostics's revenue is in the range of $10M$50M
Company Leadership
R. G.Chief Commercial Officer
T. R.Chief Financial Officer
N. D.Chief Scientific Officer- J. M.Chief Commercial Officer
- P. B.Chief Medical Officer
Employee Directory
- T. S.Senior People Partner
- R. S.Co-Founder And Head Of Data Science
- A. Z.Senior Talent Partner
- E. A.Managing Partner
- J. M.Chief Commercial Officer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
